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Introduction 
 
Throughout the second half of the twenty-first century, cardiovascular disease has 
emerged as one of the preeminent focuses of American healthcare.  Cardiovascular disease 
(CVD) is the leading cause of death in the United States.1 In 2010, cardiovascular disease 
accounted for 31.9% of the total deaths in the United States.1 While modern treatment methods 
have produced a marked decline in CVD related mortalities, cardiovascular disease continues to 
strain the American healthcare system.  The American Heart Association estimates that 40.5% of 
the population will exhibit some form of CVD by the year 2030.2  The upward spiral of CVD 
prevalence has been accompanied by a corresponding increase in CVD-related healthcare costs.  
In 2011, cardiovascular related healthcare expenditures constituted 17% of national healthcare 
costs.2  In the decade between 2001 and 2011, the cost of CVD related healthcare rose by an 
average annual rate of 6%.2 
Clearly, the problem of cardiovascular disease in America must be addressed.  In addition 
to pharmacological methods, lifestyle interventions have been utilized in order to reduce 
individual CVD risk.  Lifestyle interventions have been focused around three major goals: 
reducing the prevalence of smoking/tobacco use, reducing physical inactivity, and reducing the 
prevalence of obesity.1  Over the last several decades, campaigns against smoking have been 
effective at reducing its prevalence.1  However, the prevalence of obesity and physical inactivity 
continue to increase within the United States.1  In order to evaluate the efficacy of risk-reducing 
treatments, a working definition of cardiovascular disease and its characteristic risk factors must 
first be established. 
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 Cardiovascular disease includes any condition that involves the narrowing and/or 
blockage of blood vessels.  Narrowing of the blood vessels is a derivate of plaque accumulation 
along the vessel walls, a condition termed atherosclerosis.  Blockage of the vasculature in this 
fashion can lead to a variety of life-threatening conditions such as heart attack, stroke, angina, 
and heart failure. 
A number of factors place an individual at an elevated risk for the development and/or 
recurrence of cardiovascular disease.  The primary risk factors associated with cardiovascular 
disease are hypertension, dyslipidemia, insulin resistance, obesity (abdominal obesity has the 
highest correlation), and diabetes mellitus.1,3 Hypertension and dyslipidemia are generally 
considered more directly causal in their conveyance of risk for cardiovascular disease.  The 
expansion of arterial walls and the cardiac strain resulting from hypertension are directly 
implicated in the onset of atherosclerosis.  Likewise, the irregular lipid profiles associated with 
dyslipidemia are fundamentally connected to the accumulation of arterial plaques.  While still 
primary risk factors, insulin resistance, obesity, and diabetes mellitus are, in comparison, less 
mechanistically causal.  Ultimately, CVD risk is assessed by a continuum of different risk 
factors.3,4  Each variable conveys individual risk, but when these risk factors are seen in 
conjunction, risk for the onset of cardiovascular disease is markedly increased.  The multiplex of 
these risk factors has come to be labeled the Metabolic Syndrome.3,4  Several organizations, such 
as the World Health Organization and the National Cholesterol Education Program’s Adult 
Treatment Panel III, have produced guidelines for the clinical diagnosis of these factors. 
While not effective for the ascription of individualized CVD risk, demographic risk 
statistics serve a valuable role in the epidemiological study of CVD.  Age has long been 
established as having a positive correlation with the CVD development.  Gender can also 
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increase risk for cardiovascular disease.  Men are at a significantly higher risk for the 
development of CVD than women of a similar age.1  Family history of cardiovascular disease 
has been shown as an additional risk factor for CVD development.  Race plays a significant role 
in risk assessment for cardiovascular disease.  African-American and Hispanic populations (as 
well as other smaller racial groups) display higher rates of CVD development than the Caucasian 
population.1  This racial incongruence is most likely due to the higher prevalence of 
hypertension, obesity, and diabetes mellitus in those minority groups.1   
Obesity 
Obesity has long been implicated in the assessment of cardiovascular disease risk.  The 
onset of obesity has been linked with an increase in the prevalence of hypertension, insulin 
resistance, dyslipidemia, and diabetes mellitus.5  In this capacity, obesity serves as a powerful 
secondary risk factor for the development of cardiovascular disease.  In addition to its role as a 
secondary risk factor, obesity has also emerged as a powerful independent predictor for CVD.6 
Given the elevated risk associated with the presence of multiple CVD risk factors, the reduction 
of obesity is an ideal target for the reduction of cumulative risk for the onset of cardiovascular 
disease. 
While a variety of anthropomorphic measures are used to assess obesity, the Body Mass 
Index is the most widely used of these various metrics.  A Body Mass Index value between 25 
and 29.9 kg/m2 classifies an individual as overweight, while a BMI value of 30 kg/m2 is 
indicative of obesity.5  The prevalence of obesity has increased in parallel with the increase of 
cardiovascular disease and diabetes mellitus.1  In 2010, 68.2% of the American population was 
considered overweight or obese (34.6% of this population was considered obese).1 
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Dietary Interventions 
Dietary intervention provides an effective and efficient means by which to reduce an 
individual’s risk for cardiovascular disease.  Modulation of dietary intake can be effective for the 
reduction of obesity as well as the treatment of several other cardiovascular risk factors.  
Traditional diet programs have centered on portion control and caloric restriction.7  While the 
evidence supporting energy restriction is incontrovertible, the importance of dietary 
macronutrient content is now being explored.7 
 High-protein dietary interventions have emerged as one of several potentially viable 
alternatives to traditional carbohydrate-centric dieting.  These high-protein diet programs may 
prove effective at treating obesity and adiposity as well as other CVD risk factors such as 
elevated triacylglycerol levels, elevated cholesterol (total & LDL), reduced HDL cholesterol, and 
poor glycemic control. 
 On a cellular level, the potential efficacy of a high-protein diet is logical.  Protein is 
generally processed and utilized for various biosynthetic purposes within the body.8  Dietary 
protein in excess of that necessary for biosynthesis cannot be stored by the body.8  This is a 
departure from what is seen in the metabolism of fats and carbohydrates.  Fats and carbohydrates 
may be readily converted and stored as triacylglycerol or glycogen molecules.8  However, 
protein catabolism is significantly less stream-lined.  Metabolically fated proteins must be 
converted to high-energy metabolic intermediates.  Intermediates such as pyruvate or α-
ketoglutarate may then enter into an array of metabolic pathways (both anabolic and catabolic).8   
 From a systemic standpoint, this translates to a lower molecular energy yield and a 
subsequently greater energy requirement for the utilization of protein as a fuel source.  A variety 
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of processes such as gluconeogenesis, peptide bond synthesis, and the generation of urea are 
implicated in this increased energetic expenditure.9  Increases in energy expenditure associated 
with macronutrient consumption are designated as the thermic effect of food.9  It can also be 
viewed as the energy consumed by the processes of digestion.9  Generally, a thermic effect of 20-
35% of the energy consumed is associated with the ingestion of protein, whereas a thermic effect 
of 5-14% is observed following the ingestion of carbohydrates.9  There is conflicting evidence 
regarding the thermic effect of fat.9  While it is generally accepted that protein digestion induces 
a greater thermic effect than carbohydrate digestion, it is unclear whether this difference is 
clinically relevant.9  Further research must be conducted in order to fully understand the thermic 
effect of macronutrient digestion and the role that this metabolic expenditure plays in weight 
loss. 
 Increased satiety has also been correlated to elevated dietary protein intake.  This 
relationship is logical given the biosynthetic role of protein.  Consequently, it has been proposed 
that circulating amino acid concentrations serve as bio-indicators for satiety.9  While the current 
literature generally supports a link between satiety and protein consumption, the mechanisms 
underlying this effect have yet to be fully elucidated.9-11    The relatively complex physiological 
processes associated with the mental perception of satiety make studies of this dietary aspect 
difficult.9  
Research on the thermogenic and satiety-inducing effects of dietary protein intake 
provide sufficient evidence for the examination of a high-protein diet as an alternative to 
traditional dietary interventions.  High-protein diets may prove to be an effective means to 
reduce obesity and/or other risk factors associated with cardiovascular disease.  Numerous 
studies have examined the potential health outcomes of a high-protein dietary intervention.  This 
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review will examine the current body of evidence associated with high-protein dietary 
interventions and their role in the reduction of obesity as well as other CVD risk factors.  A total 
of 23 studies were included in this review.  Of the 24 studies, 20 were randomized control trials, 
2 were crossover trials, and the remaining 2 were meta-analyses/systematic reviews.  Studies are 
organized by experimental design, beginning with randomized control trials. 
 
Study Outcomes 
 
Randomized Control Trials 
 In the first randomized control trial (RCT), Brinkworth et al randomly assigned 66 (58) 
obese, nondietetic adults with hyperinsulinemia to one of two dietary intervention groups.12  The 
two intervention groups differed in respect to the protein content of their prescribed diets.  The 
high protein group maintained a daily diet with an approximate macronutrient distribution of 
30% protein, 40% carbohydrate, and 30% fat (as a percentage of total energy intake).  In 
contrast, the standard protein group maintained a macronutrient distribution of 15%/55%/30%, 
protein, carbohydrate, and fat, respectively.12  The two groups were subjected to 12 weeks of 
energy restriction intervention and subsequently 4 weeks of energy balance intervention.  
Following this initial 16 week period, subjects were asked to maintain a similar dietary pattern 
for an additional 52 weeks.12  Exposure methods included daily dietary checklists and direct 
supervision by a dieticians.  Food Frequency Questionnaires were distributed every three months 
throughout the 52 week follow-up period.12  At the conclusion of the 68 week study, both groups 
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exhibited similar net weight loss (P˂0.01) due entirely to fat (P˂0.001).12  Lean body mass and 
fasting glucose levels did not significantly change from baseline values.12  Both intervention 
groups significantly increased HDL-C concentrations (P˂0.001) and decreased fasting insulin, 
insulin resistance, sICAM-1, and CRP levels (P˂0.05).12  Dietary adherence greatly diminished 
throughout the 52 week unsupervised follow-up period. 
 Claessens et al conducted an RCT examining the effects of ad libitum dieting on weight 
maintenance and the reduction of metabolic risk factors. 60 (48) overweight or obese adults were 
randomly assigned to either a high protein (≥25% total energy intake) or a high carbohydrate/low 
protein group (C: ≥55% total energy intake).13  Both dietary interventions were fat reduced (30% 
of total energy intake).  The study consisted of 5-6 weeks of energy restriction followed by a 12 
week ad libitum weight maintenance period.  During the 5-6 week weight loss period, a very low 
caloric (liquid) diet was implemented.13  Throughout the weight maintenance period, subjects 
received group specific dietary supplements (HC: Maltodextrin, HP: whey/casein).13  Subjects in 
the HP group experienced significantly better weight maintenance after the initial weight loss 
(P˂0.02) than those in the LP/HC group.13  Fat mass reduction was also greater in the HP group 
(P˂0.02).13  Following the weight maintenance period, triglyceride (P˂0.01) and glucagon 
(P˂0.02) levels had increased significantly more in the HC group.13  Post-maintenance, glucose 
concentrations rose more significantly in the HP group (P<0.02).13  TC, LDL-C, HDL-C, insulin, 
HOMA, HbA1c, leptin, and adiponectin concentrations improvements did not significantly differ 
between the two groups.  Usage of whey vs. casein supplementation exhibited no significant 
effect within the HP subject group.13  The usage of a VLCD as well as group specific dietary 
supplementation may have affected the outcome of this study. 
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 Soenen et al (2010) also used dietary supplements to assess the effect of elevated protein 
intake on body weight and body fat percentage.14  In this RCT, 24 health adults with a stable 
body weight were randomly assigned to isoenergetic, ad libitum dietary interventions.14  The two 
groups differed in the variety of dietary supplement subjects were provided.14  In the protein 
supplemented group, a 2MJ milk-protein supplement was substituted for 2MJ of a subject’s 
habitual diet.14  A 2MJ carbohydrate-fat supplement was substituted into the diets of subjects in 
the control group.14  Both groups were instructed to ingest 200g of fruit and 300g of vegetables 
per day.14  Dietary consultation was provided in order to ensure proper usage of the prescribed 
dietary supplements.14  At the conclusion of the 3 month study, both groups were weight stable.14  
In comparison to the control group, the protein supplemented group exhibited significant 
reductions in body fat percentage, total fat mass, and waist circumference (P˂0.05, P˂0.05, 
P˂0.01, respectively).14  Reductions in these measure were not significant in the CHO-fat 
supplemented control group.14  Fat-free mass significantly increased in the protein supplemented 
group (P˂0.01).14  However, the observed increase in FFM was marginally significant when 
compared to FFM changes in the control group (P=0.05).14  Physical activity was unchanged for 
both groups. 
 In a more recent study by Soenen et al (2012), energy restricted high protein and low 
carbohydrate diets were examined for their potential effects on body weight reduction and body 
weight maintenance.15  In this RCT, 139(132) overweight or obese adults were randomly 
assigned to one of four dietary intervention groups.15  All diet groups participated in 12 month 
energy restriction diet.15  During the first phase, caloric intake was restricted to 33% of each 
subject’s estimated daily energy expenditure.15  After this initial 3 month phase, caloric intake 
was increased to 67% of EDEE for the remainder of the interventions (9 months).15  Protein 
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intake constituted 1.2g of protein per kilogram of body weight in the high protein groups.15  
Intake in the normal protein groups was 0.8g/kg.15  To account for the increase in caloric intake 
experienced when transitioning from 33% to 67% of EDEE, relative macronutrient composition 
was adjusted for all diet groups.15  Relative protein content of all diet groups was decreased in 
order to maintain the prescribed absolute protein intake.15  All intervention groups varied in 
respect to macronutrient composition.  The four groups were as follows: high protein/low carb, 
high protein/normal carb, normal protein/low carb, normal protein/normal carb (a full description 
of macronutrient composition is listed in the appendix).  Subjects were provided with diet 
specific menus and attended counseling sessions based on diet group.15  24-H urinary analysis 
was used to validate protein intake.15  At the conclusion of the 12 month study, dietary fat 
content displayed no significant relationship to changes in body weight, fat mass, and fat-free 
mass.15  Changes in FFM were significant for all groups, but did not significantly differ between 
groups (P˂0.001).15  Reductions in body weight and fat mass were significantly greater in the 
two HP groups than in the two NP groups (P˂0.001, respectively).15  Reductions in body weight 
and fat mass did not significantly differ between HPNC & HPLC as well as NPNC &NPLC, but 
were significant for all groups.15  There was no significant relationship between dietary 
carbohydrate content and reductions in body weight or total fat mass.15  Metabolic parameters 
decreased similarly for all diet groups (P˂0.01), with the exception of a significantly greater 
reduction in diastolic blood pressure within the HPNC group (P˂0.01).15  Weight maintenance 
as well as weight/fat mass reductions was dependent on the protein content of the diet.15 
 Due et al measured the effects of medium and high dietary protein content on body 
weight.  In this RCT, 50 overweight adults were randomly assigned to one of two dietary 
interventions16.  The two groups differed with respect to protein content.  The high protein group 
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maintained protein intake at 25% of total energy intake.  The medium protein group maintained 
protein intake at 12% of total energy intake.16  Both diet groups were fat reduced (≤ 30% total 
energy intake).16  During the first six months of the study, subjects collected all food from an on-
site shop.  Bar code scanning & regulated food distribution ensured dietary adherence during this 
phase.16  After this initial 6 month phase, subjects participated in an additional 6-12 months of 
dietary intervention.16  During this second phase, subjects maintained their diet independently.  
Subjects attended dietary counselling throughout this second phase.16  Following the 12-18 
month intervention, a 24 month follow-up was conducted.16 Subject attrition was greater than 
50% for this 24 month follow-up.  While macronutrient composition was controlled throughout 
this study, energy intake was ad libitum.16  After 6 months, the HP group lost more weight 
(P≤0.01) and exhibited a greater reduction in fat mass (P˂0.0001).16  After 12 months, weight 
loss was not significantly different between the two groups.  At 6 and 12 months, the HP group 
exhibited a greater reduction in waist circumference (6/12 month: P˂0.01), waist/hip ratio (6/12 
month: P˂0.01), and intra-abdominal fat mass (6 month: P˂0.01, 12 month: P˂0.05).16  After 6 
months, free fatty acid (FFA) concentrations were significantly lower in the HP group 
(P˂0.01).16  This effect diminished after 12 months.16  With the exception of FFA concentration 
at 6 months, blood parameters did not differ significantly.16  Subject attrition (≥50%) at the 24 
month follow-up diminished the statistical significance of data collected during that stage of the 
RCT.16 
 Farnsworth et al conducted an RCT that examined a high-protein, energy-restricted diet 
and its effect on body composition, glycemic control, and lipid concentrations.17  In this RCT, 
66(57) overweight or obese adults were randomly assigned to two dietary intervention groups.17  
The two groups differed in their respective protein content.  In the high protein group, 27% of 
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total energy intake was derived from protein, with 44% and 29% of total energy intake from 
carbohydrates and fats respectively. A second, standard-protein group was prescribed a diet 
consisting of a total energy intake of 16% protein, 57% carbohydrate, and 27% fat.17  Both 
groups participated in a 12 week energy restriction intervention followed by a 4 week period of 
energy balance.17  Throughout the study, subjects were given prescribed meal plans for their 
respective interventions.  In addition to these meal plans, subjects were supplied with key foods 
that constituted 60% of their energy intake.17  To ensure dietary adherence, subjects completed 
weighed daily food checklists and periodically (every 2 weeks) met with the same dietician.17  At 
the conclusion of the study, weight loss, total fat mass reduction, glucose, insulin, insulin 
resistance, LDL-C, HDL-C, and total cholesterol measurements were improved but not 
significantly different between the intervention groups.17  Triacylglycerol concentration was 
significantly more reduced in the HP group (P˂0.05).17  Following weight loss, glycemic 
response decreased significantly more in the HP group (P˂0.05).17  For women in the HP group, 
lean body mass was significantly better maintained (P=0.02).17  However, the effect on lean body 
mass may have been due to the ratio of protein intake to body weight.  Sex-dependent 
differences in average body weight may have skewed this finding. 
 Flechtner-Mors et al studied the effects of protein-enriched meal replacements towards 
inducing weight loss and improvements in metabolic syndrome criteria.18  In this RCT, 110 
overweight or obese adults who presented at least 3 metabolic syndrome criteria were randomly 
assigned to two dietary intervention groups.18  These groups differed with respect to dietary 
protein content.  Both diet groups participated in a 12 month energy restriction diet with a caloric 
deficit of 500 kcal/day.18  Protein content was prescribed in proportion to body weight.  The 
relative ratio of grams of protein/kilogram body weight distinguished between high and normal 
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protein diet groups.18  The high protein group was designated a 1.34g/kg protein to bodyweight 
ratio, whereas the normal protein was designated a 0.8g/kg protein to bodyweight ratio.18  Both 
diets were fat reduced (≤ 30% total energy intake).18  Augmentation of protein intake within the 
high protein group was achieved by means of protein-enriched meal replacements or snacks.  
Dietary adherence was controlled by means of dietary counseling and the submission of 3-day 
food records.18  After the 12 month intervention, the HP group exhibited significantly greater 
reductions in weight (P˂0.05) and total fat mass (P˂0.05) than the NP group.18  Reductions in 
waist circumference (P˂0.05) and sagittal diameter (P˂0.01) were also more significant in the 
HP group.18  CRP, HbA1C, serum triglycerides, and HDL-C concentrations significantly 
improved in both groups, but more significantly in the HP group (P˂0.05, respectively).18  
Fasting blood glucose and insulin levels decreased significantly in both groups, but no diet effect 
was observed (P˂0.001).18  Both groups exhibited significant decreases in the presence of the 
metabolic syndrome.  At twelve months, 64.5% of subjects in the HP group and 34.8% of 
subjects in the NP group no longer met three or more criteria for the metabolic syndrome.18  
Reduction in the presence of metabolic syndrome criteria was more significant in the HP group 
(P˂0.05).18  No adverse health effects were observed for either diet group.18 
 In another RCT, Krebs et al examined the efficacy and safety of a high protein, low 
carbohydrate diet in obese adolescents.19  46(33) obese adolescents between the ages of 12 and 
18 were randomly assigned to one of two dietary interventions.19  Both diet groups participated 
in 12 weeks of dietary restriction with subsequent follow-ups at 13, 24, and 36 weeks (only 
selected measurements were taken at 24 and 36 months).19  Dietary interventions differed with 
respect to their macronutrient composition.  The first group was prescribed a high protein, low 
carbohydrate diet and the second was prescribed a low fat, high carbohydrate diet.  
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Macronutrient composition, as a function of % total energy intake, was 32% P, 11%C, 29% F 
and 21%P, 51%C, 29%F respectively.19  30 minutes/day of vigorous physical activity was 
encouraged for both diet groups.  Dietary education and guidance was provided throughout the 
study.  3-day food records were used in order to gauge dietary adherence.19  After the 
conclusions of the 13 week intervention, BMI-Z decreased significantly in both HPLC (P=0.04) 
and LFHC groups (P=0.04), but the reduction was more significant in the HPLC group 
(P=0.03).19  Maintenance of BMI-Z reduction was significant for both groups at 24 and 36 
weeks, but no significant difference was seen between HPLC and LFHC groups.19  Reductions in 
fat mass was significant for both groups, but there was no significant difference between HPLC 
and LFHC groups.19  The HPLC group also displayed a marginally significant reduction in lean 
body mass (P=0.05).19  A significant reduction in LBM was not observed in the LFHC group.  
Both groups displayed significant decreases in TC and LDL-C, but no diet effect was observed.19  
Both groups displayed reductions in triglyceride concentrations, but a significantly greater 
reduction (3-fold greater) was observed in the HPLC group (P=0.0003 for HPLC reduction, 
P=0.03 for difference between groups).19  Fasting glucose and 2-HR glucose levels did not 
significantly improve for either group.19  Reduction in 2-HR insulin concentration was only 
significant in the HPLC group (P=0.03).19  No serious adverse health effects were observed. 
 Lasker et al conducted an RCT comparing the efficacy of a moderate protein, moderate 
carbohydrate and a high carbohydrate, low protein diet towards reducing CVD risk.20  In this 
RCT, 87(50) obese adults were randomly assigned to two isocaloric dietary intervention 
groups.20  Both intervention groups participated in a 4 month energy restriction diet with a 
caloric deficit of 500 kcal/day.20  The two groups differed in respect to the macronutrient content 
of their prescribed dietary programs.20  In the moderate protein, moderate carbohydrate group, a 
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macronutrient distribution of 30% P, 40% C, and 30% F (% total energy intake) was 
prescribed.20  In the high carbohydrate, low protein group, intake was distributed as 15%P, 
55%C, and 30%F.  Both diets were fat reduced (≤30% total energy intake).20  Subjects were 
provided with daily menu plans as well as dietary education/recommendations.20  3-day food 
records were collected throughout the study.20  At the conclusion of the 4 month study, body 
weight, BMI, and fat mass had significantly decreased for both groups.20  While decreases in 
BMI and body weight did not differ significantly differ between groups, the MPMC group 
exhibited a significantly greater reduction in fat mass when compared to the HCLP group 
(P=0.03).20  No effect of diet was observed for changes in fasting glucose and post-prandial 
glucose response (P=0.19, 2hr P=0.59, respectively).  No effect of diet was observed for 
reductions in fasting insulin levels (P=0.31).20  However, the MPMC group displayed a 
significantly greater reduction in 2-hour post-prandial insulin concentrations (P=0.03).20  A trend 
for greater reduction of total cholesterol was observed for the HCLP group, but the difference 
between groups was not significant (P=0.08).20  LDL-C concentration was reduced in the HCLP, 
while an increase in this value was seen in the MPMC group (P=0.046).20  A reciprocal 
relationship was seen for HDL-C concentrations.  HDL-C increased significantly in the MPMC 
group, while this value decreased for the HPLC group (P=0.045).20  TAG concentrations 
decreased in both groups, but the decrease was more significant in the MPMC group (P=0.04).20 
 Layman et al conducted a similar 4 month study examining the effects of a moderate 
protein diet on sustained weight loss and long-term changes in body composition and blood 
lipids.21  In this RCT, 87(50) obese adults were randomly assigned to two isocaloric dietary 
intervention groups.21  Both groups participated in a 4 month energy restriction intervention with 
a caloric deficit of 500 kcal/day.21  Following this energy restriction phase, subjects participated 
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in an 8 month weight maintenance diet phase.  Intervention groups differed with respect to 
dietary protein content.  In the high-protein group, protein constituted 30% of the subjects’ total 
energy intake.21  However, in the high-carbohydrate group, protein constituted only 15% of the 
subject’s total energy intake.21  The diet groups displayed macronutrient distributions of 
29%P/49%C/32%F and 18%P/59%C/26%F respectively.21  Dietary adherence was observed by 
means of periodic 3-day food records.21  Subjects were provided food scales and given dietary a 
series of dietary recommendations such as weighing all food items.  At the completion of the 4 
month energy restriction phase, both groups displayed significant decreases in body weight and 
total fat mass.21  Weight loss did not differ between groups at 4 months (P=0.10).21  However, 
the HP group had a significantly greater reduction in total fat mass (P˂0.04).21  Following the 8 
month weight maintenance period, weight loss remained significant, but did not differ between 
groups (P=0.18).21  Increased reduction in total fat mass for the HP group remained significant 
after the weight maintenance period (P=0.06).21  After 4 months, the HC diet produced 
significant reductions in TC and LDL-C (P˂0.01).21  Following the 8 month weight maintenance 
period, reductions in TC and LDL-C were no longer significant for the HC group and a 
significant difference was no longer observed between HC and HP groups.21  The HP group 
produced significant improvements in TAG, HDL-C, and TAG: HDL-C at both 4 and 12 months 
(P˂0.01).21 
 In an additional RCT, Leidy et al examined the effects of elevated protein intake on 
weight loss and lean body mass in women.22  In their RCT, Leidy et al randomly assigned 54(46) 
pre-obese and obese adult women to one of two dietary interventions.22  Both interventions 
consisted of a 12 week energy restriction diet with a caloric deficit of 750 kcal/day.22  
Intervention groups differed with respect to dietary protein content.  In the high protein group, 
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dietary protein constituted 30% of total daily energy intake.22  In contrast, protein intake in the 
low protein group constituted only 18% of total energy intake.22  Both diet groups were provided 
with 7 day meal plans for the duration of the study.22  In addition to these meal plans, each group 
was provided portioned quantities of diet specific foods.22  In order to control for dietary 
adherence, daily dietary intake checklists were periodically completed by study participants.22  
At the conclusion of the study, significant decreases on body weight and fat mass were observed 
for both groups, but differences between the two groups were not significant (no group effect: 
P˂0.001).22  LBM preservation was significantly higher in the HP group (P˂0.05).22  
Furthermore, LBM preservation was greater in pre-obese women than in obese subjects 
(P˂0.005).22  This effect was independent of the diet effect on LBM preservation and the two 
effects were additive.  In the NP group, significant reductions were observed for fasting glucose, 
total cholesterol, HDL-C, and LDL-C values (P˂0.001).22  The HP group displayed significant 
reductions for total cholesterol, HDL-C, LDL-C, and triacylglycerol levels, with no significant 
effect on fasting glucose (P˂0.001).22  In the previously described study by Farnsworth et al, a 
similar LBM preservation effect was observed for female subjects.17 
In a similar RCT with obese women, Noakes et al compared the effects of a high protein, 
low carbohydrate diet and a high carbohydrate towards the reduction of body weight, body 
composition, and CVD risk.23  119 (100) obese women were randomly assigned to one of two 
isocaloric dietary intervention groups.23  Both groups participated in a 12 week energy restriction 
diet with a caloric intake of ~5600kJ/day.23  Groups differed with respect to the macronutrient 
content of their prescribed diets.  In the high protein, low carbohydrate diet, macronutrient 
distribution of total energy intake was divided as 31.3 ± 0.24% protein, 44.2 ± 0.42% 
carbohydrate, and 22.1 ± 0.40% fat.23  In contrast, total energy intake was divided as 17.8 ± 
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0.21% protein, 60.8 ± 0.58% carbohydrate, and 20.1 ± 0.52% fat in the high carbohydrate, 
standard protein group.23  Food scales and selected food items were provided to all subjects.  
Dietary counseling and recommendations were provided throughout the study.  3-day food 
records were collected at two week intervals and daily food checklists were completed for the 
duration of the study.23  At the conclusion of study, body weight, total fat mass, and midriff fat 
mass decreased significantly for both groups, but there was no significant difference between the 
diets (P=0.29, P=0.16, P=0.12, respectively).23 LDL-C, HDL-C, glucose, insulin, FFA, and CRP 
decreased for both groups, but the difference between groups was not significant.23  The HPLC 
group showed a greater decrease in TAG concentrations, but only a trend was observed 
(P=0.07).23  Women with high serum TAG levels (˂1.5mmol/L) displayed a greater reduction in 
fat mass (P=0.035) and TAG concentrations (P=0.023) with the HPLC diet.23   
 While the previous studies have compared high protein and carbohydrate-centric diets, 
Luscombe-Marsh et al examined the efficacy of carbohydrate-restricted diets that differed in 
protein and fat content.24  In this RCT, Luscombe-Marsh et al randomly assigned 73(57) 
overweight or obese adults to two dietary intervention groups.24  Within the low fat, high protein 
group, protein intake constituted 34% of total energy intake, while fat accounted for 29%.24  In 
the high fat standard protein group, protein constituted only 18% of total energy intake, while fat 
intake increased to 45%.24  Both groups participated in a 12 week energy restriction intervention 
with a caloric deficit of 30% of each subject’s calculated caloric maintenance value.24  A 4 week 
energy balance phase followed the initial energy restriction period.24  Subjects followed fixed-
menu plans and were supplied intervention specific foods (60% of energy intake was 
provided).24   Dietary adherence was controlled by means of periodically submitted dietary 
intake checklists.24  Both LFHP and HFSP groups exhibited significant decreases in body 
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weight, total fat mass, abdominal fat mass, and lean body mass.24  No effect of diet was observed 
for these measures (P˂0.001, for all measures).24  However, male subjects lost 2% more of their 
total body weight than did female subjects (time-by-sex int. P=0.03).24  Fasting glucose 
concentrations did not significantly change from baseline in either group.24  Improvements were 
seen in fasting insulin, HOMA insulin resistance and fasting FFA (P˂0.001).24  However, no 
significant difference was seen between LFHP and HFSP for these values.24  Both groups 
displayed significant reductions in total cholesterol, LDL-C, and triglycerol concentrations 
(P˂0.001, P=0.005, P˂0.005, respectively).24  Both groups displayed significant increases in 
HDL-C concentrations (P˂0.001).24  Blood lipid profiles significantly improved for both groups 
but did not significantly differ between groups.24 No negative effects on bone turnover or renal 
function were observed.24 
 Muzio et al conducted a study examining the effects of moderate dietary macronutrient 
variation on reducing cardiovascular disease risk factors in patients with the metabolic 
syndrome.25  In this RCT, 100 obese adults with the metabolic syndrome were randomly 
assigned to two dietary intervention groups.25  The two groups differed with respect to the 
prescribed macronutrient composition of their diet program.  In the low-carb, high protein group, 
total energy intake was divided as 19% protein, 48% carbohydrate, and 33% fat.25  Total energy 
intake was divided as 13% protein, 65% carbohydrate, and 22% in the high carbohydrate, low 
protein diet group.25  Both groups participated in a 5 month energy restricted intervention with a 
caloric deficit based upon each individual’s estimated daily energy expenditure.25  Physical 
activity was encouraged and group counseling was provided throughout the study.25  Dietary 
adherence was measured via a 20-question adherence questionnaire.  At the conclusion of the 
study, body weight, BMI, waist girth, diastolic blood pressure, TC, blood glucose, insulin, and 
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HOMA values decreased significantly in both groups.25  However, there was no group effect 
observed for these risk factors.25  HDL-C did not significantly decrease from baseline in either 
group.  Systolic blood pressure (P˂0.001) and serum TAG levels (P˂0.05) decreased more 
significantly in the HPLC group.25  Decreases in TAG levels were affected by weight loss 
(P˂0.01) and the reduced carbohydrate content of the diet (P˂0.05).25  Only the HCLP group 
displayed a significant decrease in LDL-C from baseline (P˂0.01).  Both groups displayed a 
reduction in the prevalence of the metabolic syndrome, but the difference between groups was 
not significant. 25  While dietary adherence was well maintained throughout the study, the 
relatively minimal variation in protein content may have affected some measured outcomes. 
 In a large RCT study, Sacks et al examined the efficacy of weight-loss diets that varied in 
protein, carbohydrate, and fat composition.26  811(645) nondietetic, overweight/obese adults 
were randomly assigned to one of four dietary intervention groups.26  Macronutrient composition 
of the four diets was as follows (as a % of total energy intake): High protein/Low fat diet: 25% 
protein, 55% carbohydrate, 20% fat, High protein/High fat diet: 25% P, 35% C, 40% F, Average 
protein/Low fat: 15% P, 65% C, 20% F, Average Protein/High fat: 15% P, 45% C, 40%F.26  All 
intervention groups participated in a 24 month energy restriction diet with a caloric deficit of 750 
kcal/day.26  Measurements were taken at 6 month intervals.  5-day food records and non-
consecutive 24-hour dietary recalls were utilized to assess dietary intake of study participants.26  
At the conclusion of the 2 year study, differences in dietary content of protein and fat had no 
significant effect on weight loss (P=0.11, P=0.94).26  Carbohydrate level had no impact on 
weight loss throughout the study.26  Change in waist circumference was significant for all 
groups, but did not significantly differ between groups.26  The majority of weight loss occurred 
during the first 6 months and did not significantly differ between intervention groups.26  After 2 
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years, the two low fat diets decreased LDL-C more significantly than the two high fat groups 
(P=0.001).26  Similarly, the highest-CHO diet decreased LDL-C more significantly than the 
lowest-CHO group (P=0.01).26  The lowest-CHO group increased HDL-C concentrations more 
significantly than did the highest-CHO group (P=0.02).26  All diets reduced blood pressure and 
TAG levels significantly.26  All diets except the highest-CHO group displayed significant 
reductions in fasting insulin concentrations.26  7% of study participants experienced severe 
adverse health effects, but there was no significant difference in the prevalence of these effects 
between diet groups.26  The efficacy of the four dietary interventions was not greatly impacted by 
the respective macronutrient composition of each diet.26 
 In another RCT, Skov et al examined the effect of dietary protein and carbohydrate 
content on obesity within an ad libitum treatment structure.27  In this study, 65 health, overweight 
or obese adults were randomly assigned to one of three 6 month dietary intervention groups.27  A 
control group was used in which macronutrient content was not regulated.27  The two modified 
diets were fat reduced (≤ 30% TEI) and caloric intake was ad libitum.27  Groups differed with 
respect to their protein and carbohydrate content.  In the high protein group, total energy intake 
was divided as 25% protein, 45% carbohydrate, and 30% fat.27  Total energy intake for the high 
carbohydrate group was divided as 12% protein, 58% carbohydrate, and 30% fat.27  All food 
items were provided via an on-site grocery store.27  All food purchases were recorded and 
consultation was provided to assist in the selection of diet-appropriate food items.27  7-day food 
records were collected throughout the study and alcohol consumption was regulated.27  Urinary 
analysis was conducted to ensure dietary adherence.27  At the conclusion of the study, body 
weight and composition had significantly improved for both groups (in comparison to the control 
group), but the HP group experienced significantly greater reductions in weight, fat mass, and 
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abdominal fat mass (P˂0.02, P˂0.0001, P˂0.0001, respectively).27  In comparison to the 
control group, total cholesterol and HDL-C significantly decreased in both the HP and HC 
groups.27  Plasma free fatty acids decreased in the HP group, but no change was observed for the 
HC group (P˂0.05).27   At 3 months, plasma TAG’s had decreased for the HP group and 
increased for the HC group (P=0.001).27  Differences in plasma TAG’s were not significant at 6 
months.27 
 Tang et al conducted an RCT comparing the effects of normal and high protein diets 
towards improving body composition and the incidence of the metabolic syndrome.28  In this 
RCT, 55(43) overweight and obese men were randomly assigned to one of two isocaloric, 
energy-restricted dietary interventions.28  The study was 12 weeks in duration and an energy 
deficit of 750 kJ/day was maintained for both diet groups.28  Diets differed with respect to 
macronutrient composition.28  Total energy intake for high protein and normal protein groups 
was distributed as 25/50/25% and 15/60/25% protein, carbohydrate, fat, respectively.28  Dietary 
intake was assessed by means of daily food checklists (completed weekly).28  Study participants 
were provided dietary counseling for the duration of the study.28  At the conclusion of the 12 
week study, reductions in body weight (P˂0.0001) and total fat mass (P˂0.0001) were 
significant for both groups, but not significantly different between HP and NP groups.28  Lean 
body mass was more significantly preserved in the HP group (P˂0.05).28  TC (P˂0.001), HDL-
C (P˂0.001), LDL-C (P˂0.001), TAG (P˂0.001), insulin (P˂0.05), glucose (P˂0.05), insulin 
resistance (P˂0.05), and blood pressure (P˂0.001) measurements improved independent of 
dietary protein content.28  Overweight subjects lost less lean body mass than obese subjects, 
independent of dietary protein content.28  Obese subjects reduced TAG concentrations more 
significantly than overweight subjects, independent of protein intake (P˂0.05).28 
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 In another RCT, Belbrajdic et al examined the weight reducing effects of two moderate 
energy-restriction diets.29  In this study, 123 (76) overweight or obese men were randomly 
assigned to one of two energy-restricted dietary intervention groups.29  Dietary interventions 
were 12 weeks in duration with a daily caloric deficit of ~1650 kJ/day for both groups.29  Diets 
differed with respect to macronutrient composition.  In the high protein group, total energy 
intake was divided as 33%, 37%, and 30% for protein, carbohydrate, and fat, respectively.29  
Total energy was divided as 21%, 51%, 28% P/C/F in the high carbohydrate group.29  Subjects in 
both groups were provided with 60% of their daily energy intake.29 3-day food records and daily 
dietary checklists were completed throughout the duration of the study.29  At the conclusion of 
the study, reductions in body weight (P˂0.0001) and total fat mass (P˂0.0001) were significant 
for both groups, but did not significantly differ between groups.29  Reductions in abdominal fat 
mass were more significant in the HP group (P˂0.02).29  Significant reductions in fasting 
insulin, insulin sensitivity, adiponectin, and leptin concentrations were seen in both diets 
(P˂0.0001, P˂0.0001, P˂0.001, P˂0.0001, respectively).29  No diet effect was observed for 
these measures. 
 In the final RCT, Te Morenga et al compared the efficacy of two diets on reducing 
weight in women at risk for the metabolic syndrome.30  In this RCT, 87(72) overweight or obese 
women were assigned to one of two energy-restricted dietary intervention groups.30  Dietary 
interventions were 8 weeks in duration with a caloric deficit of 2000-4000 kJ/day for both 
groups.30  Diets differed with respect to macronutrient composition.  In the high protein group, 
total energy intake was divided as 28%, 40%, 29%, protein, carbohydrate, and fat, respectively.30  
Total energy intake was divided as 22%, 51%, 23%, P/C/F for the high carbohydrate diet.30  In 
addition to the designated macronutrient composition, the high carbohydrate group was 
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instructed to consume greater than 35g of fiber per day.30  Subjects were provided group specific 
food items and dietary recommendations were made for the duration of the study.30  3-day food 
records were used to gauge dietary adherence.30  At the conclusion of the 8 week interventions, 
both diets were effective at reducing waist circumference, total cholesterol, LDL-C, TAG’s, 
fasting glucose and blood pressure (CI 95%, respectively).30  No diet effect was observed for 
these measures.30  The HP group experienced greater reductions in body weight, total fat mass, 
and diastolic blood pressure (P˂0.039, P˂0.029, P˂0.005, respectively).30  HDL-C increased in 
both groups, but no effect of diet was observed (CI: 95%).30 
Cross-over Studies 
 Two cross-over studies were analyzed in addition to the 19 previously discussed 
randomized control trials.  In the first crossover study, Appel et al examined the effect of 
macronutrient intake on blood pressure and serum lipids.31   In this study, 164 healthy, 
hypertensive adults participated in 18 weeks of dietary modulation.31  Subjects participated in 
three 6 week feeding periods that differed with respect to macronutrient composition.  Feeding 
periods were separated by washout periods of 2-4 weeks.31  In the protein-rich feeding period, 
total energy intake was divided as 25%, 48%, 27%, protein, carbohydrate, and fat, respectively.  
During the carbohydrate rich feeding period, total energy intake was 15%, 58%, 33%, P/F/C, 
respectively.  In the final feeding period, a diet rich in unsaturated fat was consumed with a total 
energy intake of 15%, 48%, 37%, P/F/C, respectively.  All food was provided and prepared on-
site.  A 7-day menu cycle was utilized during all feeding periods.  Weight was regulated for the 
duration of the study and dietary compensations were made in order to keep weight within 2% of 
baseline.  At the conclusion of the 18 week study, the high protein diet was more effective than 
the high carbohydrate diet at reducing systolic blood pressure, LDL-C, HDL-C, and TAG’s 
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(P=0.02, P=0.01, P=0.02, P˂0.01, respectively).  In comparison to the high carbohydrate group, 
the high unsaturated fat group was more effective at reducing systolic blood pressure (P=0.05) 
and TAG’s (P=0.02) and improved HDL-C more significantly (P=0.03).  Substitution of protein 
or unsaturated fat for carbohydrate intake lowered blood pressure and improved blood lipid 
profiles. 
 In a second crossover trial, Jenkins et al examined the effects of a high-protein diet on 
reducing serum lipids in hyperlipidemic adults.32  In this study, 20 hyperlipidemic adults 
participated in two 1 month dietary interventions.32  The two intervention diets differed with 
respect to macronutrient composition.32  In the high protein test group, total energy intake was 
divided as 27.4%, 46.7%, and 25.6%, protein, carbohydrate, and fat, respectively.32  In the high 
carbohydrate control group, total energy intake was constituted by 15.6%, 58.6%, and 25.5%, 
protein, carbohydrate, and fat, respectively.32  Differences in dietary macronutrient intake were 
accomplished by means of a macronutrient-controlled dietary supplement (a modified bread).32  
At the conclusion of this crossover trial, no significant differences in total cholesterol or HDL-C 
were observed between HP and control groups.32  TAG levels decreased more significantly in the 
HP group than in the HC control group (P=0.003).32 
 
Results & Conclusions 
 
Results 
25 
 
Of the 21 randomized control and crossover trials examined, 19 measured for changes in 
body weight.12-30  In 7 of these 19 studies, high protein diet groups displayed significantly greater 
reductions in body weight than did other study groups.13,15,16,18,19,27,30  The remaining 12 studies 
did not exhibit an effect of diet on weight loss.12,14,17,20-26,28,29 
Total blood cholesterol concentrations were measured in 19 of the 21 studies examined in 
this review.12,13,15-28,30-32  A diet effect on total cholesterol levels was observed in a single study.  
In the study by Layman et al (2009), total cholesterol reductions were significantly greater in the 
high carbohydrate control group after four months of dietary intervention.21  However, no diet 
effect was observed at the conclusion of the twelve month study.21  No other studies that 
recorded total cholesterol values observed an effect of diet composition on this metric.  Studies 
by Brinkworth et al and Appel et al did not find significant reductions in total cholesterol for any 
diet group.12,31 
 19 of the 21 studies examined in this review measured blood LDL-cholesterol 
concentrations.12,13,15-28,30-32  Of the 19 studies that measured this value, five observed an effect of 
diet composition.20,21,25,26,31  In the crossover trial by Appel et al (2001), the high protein diet 
period displayed a significantly greater reduction in LDL-C values than was observed during 
other diet periods.31  In contrast, 4 studies observed a significantly greater reduction of LDL-C 
concentrations for the high carbohydrate control group than was seen in the high protein diet 
group.20,21,25,26  In the RCT by Brinkworth et al, no significant reduction in LDL-C 
concentrations was observed for either diet group.12  No effect of diet composition on HDL-C 
concentrations was seen for 14 of the 19 studies that recorded this metric.12,13,15-19,22-24,27,28,30,32 
 19 of the 21 studies examined in this review measured blood HDL-cholesterol 
concentrations.12,13,15-28,30-32  Of these 19 studies, five observed an effect of diet 
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composition.18,20,21,26,31  In studies by Flechtner-Mors et al, Lasker et al, and Layman et al 
significantly greater improvements in HDL-C concentrations were seen in the high protein group 
than were seen in control groups.18,20,21  In studies by Sacks et al and Appel et al, HDL-C 
improvements varied with carbohydrate content and unsaturated fat content, respectively.26,31  In 
the RCT by Muzio et al, HDL-C values did not significantly change from baseline for any diet 
group.25  No effect of diet composition on HDL-C concentrations was seen for 14 of the 19 
studies that recorded this metric.11-13,15-17,19,22-25,27,28,32 
 Serum triglyceride concentrations were measured in 19 of the 21 studies examined in this 
review.12,13,15-28,30-32  13 of the 19 studies that recorded this metric observed significantly greater 
reductions in serum triglyceride concentrations within high protein diet groups.13,16-23,25,27,31,32  In 
the study by Brinkworth et al, no significant change from baseline triglyceride concentrations 
was seen for any diet group.12  No effect of diet composition on serum triglyceride concentration 
was observed for 6 of the 19 studies that recorded this metric.12,15,24,26,28,30 
 Total fat mass was measured in 19 of the 21 studies examined in this review.12-30  Of 
these 19 studies, 10 observed significantly greater reductions in total fat mass for high protein 
diet groups in comparison to control diet groups.13-16,18-21,27,30  The remaining 9 studies that 
recorded this metric did not show an effect of diet composition on fat mass reduction.12,17,22-
26,28,29
 
 Abdominal fat mass was measured in 13 of the 21 studies examined in this review.13-18,23-
27,29,30
  6 of the 13 studies that recorded this metric observed significantly greater reductions in 
abdominal fat mass within high protein diet groups.13,14,16,18,27,29  The other 7 studies did not 
display an effect of diet composition on reductions in abdominal fat mass.15,17,23-26,30 
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Conclusions 
 Within the body of evidence examined in this review, a high protein diet did not 
significantly differ from control diets with respect to the reduction of obesity and the 
improvement of cardiovascular disease risk factors. High protein diets were more effective than 
control diets at reducing body weight in 7 of the 21 studies examined.13,15,16,18,19,27,30 However, 
the majority of studies did not show a significant difference in weight reduction between high 
protein and control diets. 
Changes in total cholesterol, LDL-C, and HDL-C concentrations did not significantly 
differ between high protein and control diets for the majority of the studies that were reviewed.  
High protein diet groups did not show significantly greater reductions in total cholesterol (in 
comparison to control diets) in any of the 21 studies.  Similarly, reductions in LDL-C 
concentrations were only significantly greater for high protein diet groups in the study by Appel 
et al.31  In 4 of the 21 studies, high protein diets were less effective at reducing LDL-C than 
control diets.20,21,25,26  Most studies did not observe a significantly greater improvement of HDL-
C concentrations for high protein diet groups (only 3 groups observed such an effect).18,20,21  
Despite these minor variations, a high protein diet did not produce significantly greater 
improvements in total, LDL, or HDL cholesterol concentrations for the majority of the studies 
examined in this review. 
 High protein diet groups displayed significantly greater reductions in serum triglyceride 
concentrations in 13 of 21 studies.13,16-23,25,27,31,32  While far from conclusive, the findings of this 
review suggest that, in comparison to control diets, a high protein diet may be effective at the 
reduction of serum triglyceride levels.   
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 High protein diet groups displayed significantly greater reductions in total fat mass in 10 
of the 21 studies examined within this review.13-16,18,19,27,30  These results are intriguing, but 
conflicting.  In comparison to control diets, high protein diets may be more effective at reducing 
total fat mass, but further research must be done in order to confirm or deny this effect. 
 In comparison to control diet groups, high protein diet groups displayed significantly 
greater reductions in abdominal fat mass in 6 of the 21 studies examined in this 
review.13,14,16,18,27,29  However, this metric was only recorded in 13 of the 21 studies.13-18,23-27,29,30  
A high protein diet may provide beneficial effects towards the reduction of abdominal fat mass, 
but the body of evidence within this review is not large enough to confirm or deny such a claim. 
 The evidence presented within this review suggests that a high protein diet may be 
effective at reducing body weight, serum triglyceride concentrations, and total/abdominal fat 
mass.  However, data regarding these metrics is conflicting.  A larger, more inclusive analysis 
may provide definitive conclusions as to the efficacy of a high protein diet towards reducing 
obesity and improving cardiovascular disease risk factors. 
Evidence-based Practice 
 As modern research continues to explore the potential benefits of a high protein diet, 
physicians may begin to translate these findings into a variety of clinical applications.  Once the 
effects of a high protein diet are better understood, this diet may be incorporated into the 
treatment of obesity, cardiovascular disease, and diabetes.  Without definitive evidence 
supporting the effects of a high protein diet, its usage as a treatment for specific health problems 
may be limited. 
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Ultimately, the effectiveness of any diet plan is affected by dietary adherence.  Within the 
context of individual adherence, high protein diets may prove to be more palatable for some 
patients.  The usage of a high protein diet for the treatment of non-compliant patients may have 
some clinical utility. 
Further Research 
Further research must be done in order to fully elucidate the benefits of a high protein 
diet.  Within the context of this review, the measurement of glycemic control was not 
standardized.  The lack of uniform measurement made the glycemic effects of a high protein 
difficult to effectively analyze.  Research focused specifically on glycemic control would 
produce a more wholistic representation of the efficacy of a high protein diet towards improving 
cardiovascular and/or metabolic health. 
Continued research on the satiety-inducing effects of protein consumption may also 
prove beneficial.  Elucidation of the mechanisms underlying satiety could open the door to a 
number of nutritional and pharmacological therapies. 
In addition to these avenues of research, the effects of a high protein diet on reducing 
obesity as well as risk factors for cardiovascular disease must continue to be examined. 
Appendices 
High-Protein Summary Table 
Author N Age (yrs.) 
mean/me
dian 
Subject/BMI Duration Protein Other 
Diet(s) 
Exposure 
Measures 
Measures/Outco
mes 
Randomized Controlled Trials 
Belobrajdic et al 
201029 
123 
(76) 
µ 51±1 
years 
Overweight/O
bese Men 
BMI µ 
32.8±0.5 
12 weeks  
moderate 
 
energy 
restriction 
(7000kJ/d
ay) 
HP 
(Isocaloric, 
both energy 
rest.) 
P:33% 
C:37% 
F: 30% 
(1651 
kcal/day def) 
HC 
(Isocaloric, 
both energy 
rest.) 
P: 21% 
C: 51% 
F: 28% 
(1627 
kcal/day def) 
Dietary 
consulation/gui
dance 
 
60% of energy 
intake supplied 
 
3DFR 
(weighed) 
 
Daily Dietary 
Checklist 
No sig. diff. 
between weight 
loss and total fat 
mass reduction 
between groups. 
 
HP group had 
greater reduction 
in abdominal fat 
mass. 
 
Improvements in 
fasting insulin, 
insulin sensitivity, 
adiponectin and 
leptin levels seen 
for both groups, 
no sig. diff. 
between groups. 
 
Changes in IGF 
system derivative 
of weight loss and 
occured 
independent of 
dieatry protein 
content. 
1 
 
Brinkworth et al 
200412 
66 (58) 
43 
comple
ted 
20-65 
years 
µ 50.2 
years 
Obese, 
nondietetic, 
with 
hyperinsuline
mia 
BMI 27-43 
BMI µ 34 
68 weeks 
total 
 
12 wks. 
Energy 
restriction  
 
(30%) 
4 wks. 
Energy 
balance 
 
52 weeks 
additionals 
HP (fat 
reduced) 
(% total 
energy 
intake) 
P: 30% 
C: 40% 
F: 30% 
SP (fat 
reduced) 
(% total 
energy 
intake) 
P: 15% 
C: 55% 
F: 30% 
Daily Diet 
Checklist 
Supervision by 
dietician 
(enegry 
restriction/bala
nce) 
 
Food 
Frequency 
Questionnaire 
(every three 
months in 12 
month follow-
up period) 
Both groups: net 
weight loss, incr. 
HDL, dec. fasting 
insulin, dec. 
insulin resistance, 
dec. sICAM-1, 
and dec. CRP. (at 
68 weeks) 
 
No sig. 
differences 
between diets 
among measured 
values at 68 
weeks. 
 
No sig. decreases 
in BP or glucose 
 
Poor dietary 
adherence in both 
diet groups. 
Claessens et al 
200913 
(60) 48 30-60 
years 
µ 45-46 
years 
Adults 
Overweight/O
bese 
BMI µ32-33 
18 wk HP (≥25% 
energy) 
Fat 
Reduced 
(30% 
energy) 
HC (≥55% 
energy) 
Fat 
Reduced 
(30% 
energy) 
VLCD (5-6 wk) 
 
ad libitum 
main. (12wk) 
 
Dietary 
Counseling 
Protein/Carb. 
Supplementati
on (by group) 
HP diet group sig. 
better weight 
maintenance and 
fat mass 
reduction than HC 
group 
 
Triglyceride, 
glucagon incr. 
more sig. in HC 
group 
 
Fasting Glucose 
incr. more sig. in 
HP group 
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Due et all 200416 50 19-55 
years 
µ 39 
years 
BMI 26-34 
µ 30-31 
6 months 
6-12 
months 
24 months 
HP 
(% total 
energy 
intake) 
Protein 25% 
Normal in fat 
(<30% E) 
MP 
(% total 
energy 
intake) 
Protein 12% 
Normal in fat 
(<30% E) 
ad libitum 
dieting 
 
monitored, 
experimental 
grocery shop 
 
dietary 
counselling 
 
7DFR 
HP had greater 
decrease in 
weight at 6 mo., 
not sig. diff. at 12 
months, greater 
decrease FM 
(6mo.) 
 
HP had greater 
loss of abdominal 
fat mass and 
higher proportion 
of individuals with 
>10 kg weight 
loss. 
 
HP greater 
reduction in FFA 
(6) 
 
Blood profile not 
sig. diff. except 
FFA 
Farnsworth et al 
200317 
66 (57) 20-65 
years 
µ48-51 
Obese/Overw
eight 
Inclusion 
factors: 
fasting insulin 
>12 mU/L 
BMI 27-43 
BMI µ 34 
12 weeks 
energy 
restriction 
(30%) 
 
4 weeks 
energy 
balance 
HP 
(% total 
energy 
intake) 
P: 27% 
C: 44% 
F: 29% 
SP 
(% total 
energy 
intake) 
P: 16% 
C: 57% 
F: 27% 
prescriptive 
fixed-menu 
plans 
 
Daily food 
checklists 
No sig. diff. in 
weight loss, total 
fat mass 
reduction, 
glucose, insulin, 
insulin 
resistance?, LDL, 
HDL, and 
cholesterol 
 
HP: greater 
decrease in 
glucose AUC, 
TAG 
 
Women in HP 
exp. Greater 
3 
 
preservation of 
lean body mass 
Flechtner-Mors et al 
201018 
110 25-70 
years 
µ ~50 
(variance 
group-
group) 
Obese/Overw
eight 
(3 or more 
MS criteria) 
BMI: 27-45 
BMI µ36 
1 yr. 500 kcal/day 
def. 
HP: 
1.34g/kg 
body weight 
Fat 
Reduced 
(30% 
energy) 
500 kcal/day 
def. 
NP: 0.8g/kg 
body weight 
Fat 
Reduced 
(30% 
energy) 
HP Group: 
Protein-
enriched meal 
replacements 
 
Dietary 
Counseling 
(Weekly - 
Monthly) 
 
3-Day Food 
Records 
0,3,6,9,12 
months 
HP lost more 
body weight and 
fat mass than NP 
group. 
 
Fat-free mass-
similar reduction 
across groups. 
 
HP greater 
reduction in 
TAGs, CRP, 
HbA1C, waist 
circ., and sagital 
circumference. 
 
HP group 
modestly higher 
decline in MS 
criteria (3 or 
more) than NP 
group. 
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Krebs et al 201019 46 (33) 12-18 
years 
µ 13-14 
years 
Obese 
adolescents 
≥175% ideal 
body weight 
BMI µ38-40 
13 weeks 
13,24,36 
week 
measurem
ents 
HP-LC 
P: 32% 
C: 11% 
F: 57% 
LF-(HC, 
relative) 
P: 21% 
C: 51% 
F: 29% 
3DFR 
 
Physical 
activity 
encouraged 
 
Dietary 
education, 
guidance 
 
Subjective 
assessments 
BMI-Z sig. 
reduced in both 
groups, sig. 
greater reduction 
in HPLC group. 
 
Maintenance of 
BMI-Z decrease 
was seen in both 
groups, no sig. 
diff. between 
groups. 
 
Loss of lean body 
mass was not 
spared in the 
HPLC group. 
 
HPLC greater 
reduction TAG's, 
2-hour insulin. 
Lasker et al 200820 87 (50) 40-56 
years 
µ 47 
years 
 
BW < 140 kg. 
BMI >26 
4 months 
(500 
kcal/day 
deficit) 
HP 
(Isocaloric) 
P: 30% 
C: 40% 
F: 30% 
NP 
(Isocaloric) 
P: 15% 
C: 55% 
F: 30% 
3DFR 
 
Provided daily 
menu plan, 
dietary 
education, 
reccomendatio
ns 
No sig. diff. in 
weight loss 
between groups 
 
HP-Greater 
reduction of fat 
mass, greater 
decr. TAG, 
greater incr. HDL-
C, greater decr. In 
post-prandial INS 
response 
 
NP-greater 
decrease LDL-C 
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Layman et al 200921 130 40-56 
years 
µ 
45.4±1.2 
years 
Obese Adults 
<140 Kg. 
BMI >26 
BMI µ 
32.6±0.8 
4 months 
weight 
loss (500 
kcal/day 
deficit) 
 
8 month 
weight 
main. 
HP (30% P) 
P: 29% 
C: ~49% 
F: 32% 
 
4+12 mo. 
Values not 
sig. diff. 
HC (15% P) 
P: 18% 
C: 59% 
F: 26% 
 
4+12 mo. 
Values not 
sig. diff. 
3DFR 
 
Provided food 
scales, recc. Of 
weighing all 
food, diet. 
Meetings 
No sig. diff. in 
weight loss 
between diet 
groups. 
 
HP group had 
greater decrease 
in fat mass, TAG, 
TAG:HDL, and a 
greater increase 
in HDL-C than the 
HC group at 4+12 
months. 
 
HC group had 
greater decrease 
in total choesterol 
and LDL-C at 4 
months, but not at 
12 months. 
Leidy et al 200722 54 (46) 28-80 
years 
µ 46, 53 
years 
Women, ≥ 21 
years, non-
diabetic, 
normal blood 
profile, non-
smoker 
 
BMI 26-37 
BMI µ 30 
12 weeks 
(750 
kcal/day 
deficit) 
HP 
30% total 
energy 
intake from 
protein 
LP 
18% total 
energy 
intake from 
protein 
Subgrouped 
into pre-obese 
and obese 
pops. 
 
7-day menus 
 
daily dietary 
intake checklist 
log 
HP group had 
greater 
preservation of 
LBM. 
 
Sig. decrease in 
body weight and 
fat mass for both 
groups.  Diff. 
between groups 
not sig. 
 
Lipid-lipoprotein 
profile and BP 
improved and 
kidney fxn. 
Minimally 
changed with 
energy restriction, 
6 
 
independently of 
protein intake. 
Luscombe-Marsh et 
al 200524 
73 (57) 20-65 
years 
µ 48-53 
years 
Overweight/O
bese Adults 
BMI 27-40 
BMI µ 33.8 
12 weeks 
energy 
restriction 
(30%) 
 
4 weeks 
energy 
balance 
LF-HP 
P: 34 ± 
0.8% 
F: 29 ± 1% 
HF-SP 
P: 18 ± 
0.3% 
F: 45 ± 0.6% 
Fixed-menu 
plans 
 
Provided food 
 
Daily dietary 
intake 
checklists 
Both diet groups 
showed 
decreases in : 
weight, fat mass, 
total chosterol, 
LDL, TAG, fasting 
insulin, insulin 
resistance, FFA.  
HDL also 
increased.  
Effects were not 
sig. diff. between 
groups 
 
No sig. change in 
bone turnover, 
inflammation, or 
renal fxn. 
 
LF-HP test meal 
had greater 
satiety effect 
 
No sig. effect on 
fasting plasma 
glucose for either 
group. 
 
Decrease in REE 
7 
 
not sig. diff. 
between diet 
groups. 
 
Decrease in TEF 
with weight loss 
was smaller in 
LF-HP group. 
Muzio et al 200725 100 >18 years 
µ 53 
years 
obese, 
metabolic 
syndrome 
BMI ≥ 30 
BMI µ 37 
5 months 
(500 
kcal/day 
individuali
zed caloric 
deficit) 
LC-HP (high 
monounsatu
rated fat) 
P: 19% 
C: 48% 
F: 33% 
HC-LP 
P: 13% 
C: 65% 
F: 22% 
Monlthy, group 
sessions 
 
Adherence 
questionnaire 
No sig. diff. in 
HDL from 
baseline 
 
HC-LP:sig. decr. 
In LDL cholesterol 
 
LC-HP: greater 
decr. In the prev. 
of hypertension 
and 
hypertriacylglycer
olemia, TG conc., 
and systolic BP 
 
Sig. decrease, but 
no group diff. in 
weight, BMI, waist 
girth, cholesterol, 
glucose, insulin, 
HOMA 
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Noakes et al 200523 119 
(100) 
20-65 
years 
µ 49 
years 
Obese 
Women 
BMI 27-40 
BMI µ 32 
12 weeks 
energy 
restriction 
(30%) 
 
4 weeks 
energy 
balance 
HP 
(Isocaloric, µ 
5310 kJ) 
P: 31.3 ± 
0.24% 
C: 44.2 ± 
0.42% 
F: 22.1 ± 
0.40% 
SP 
(Isocaloric, 
µ 5219 kJ) 
P: 17.8 ± 
0.21% 
C: 60.8 ± 
0.58% 
F: 20.1 ± 
0.52% 
Dietary 
Guidelines, 
Reccomendati
ons, quasi ad 
libitum 
 
Provided food 
 
Dietary 
Counselling 
 
Daily Food 
Checklist 
 
3-d weighed 
food record 
every 2 week 
interval. 
No sig. diff. in 
weight loss or fat 
loss (among 
completers) 
between diet 
groups. 
 
No sig. diff. 
between groups 
for decr. observed 
with LDL, HDL, 
glucose, insulin, 
FFA, and C-
reactive proteins. 
 
HP greater 
reduction in TAG 
conc. 
 
Subjects with 
elevated TAG 
conc.'s showed 
greater decrease 
in midriff fat, total 
fat mass and TAG 
levels. (Greater 
decrease in HP 
group) 
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Sacks et al 200926 811 
(645) 
30-70 
years 
µ 50-52 
years 
Overweight, 
Obese, 
nondietetic, 
compliant 
BMI 25-40 
BMI µ 33 
24 months 
(750 
kcal/day 
deficit) 
HP 
(P/F/C) 
25/20/55% 
25/40/35% 
NP 
(P/F/C) 
15/20/65% 
15/40/45% 
5DFR 
 
24-Hour Recall 
 
Group/individu
al counselling 
 
Questionnaire 
25+15% Protein 
diet groups lost 
similar weight. 
40+20% Fat diet 
groups lost similar 
weight. 
Carbohydrate 
level had no 
effect on weight 
loss. 
 
No sig. 
diff.between 
groups for change 
in waist circ., 
decr. In BP, and 
decr. In TG lvls. 
 
All diets except 
Highest-CHO 
decreased fasting 
insulin, decrease 
was larger with 
HP diet than NP 
diet. 
 
2 LF + Highest-
CHO diet more 
effective at 
decreasing LDL-
C. 
 
Lowest CHO diet 
increased HDL-C 
more than 
Highest CHO diet. 
 
Reduced-calorie 
diets result in 
clinically 
10 
 
meaningful weight 
loss regardless of 
which 
macronutrients 
they emphasize. 
Skov et al 199927 65 18-56 
years 
µ 37-39 
Healthy, 
overweight 
and obese 
 
BMI ≥ 25 
µ 30 
6 months HP (fat 
reduced) 
(% total 
energy 
intake) 
P: 25% 
C: 45% 
F: 30% 
LP (fat 
reduced) 
(% total 
energy 
intake) 
P: 12% 
C: 58% 
F: 30% 
ad libitum 
dieting 
 
recorded/regul
ated grocery 
purchase w/ 
consultation 
 
7DFR (alcohol 
consumption) 
 
Urine analysis 
(N excretion) 
HP group had 
greater decrease 
in weight, fat 
mass, and 
abdominal fat 
mass.  
 
HP sig. 
decreased TAG 
(at 3mo, not 6 
mo) and free fatty 
acids. 
 
No sig. diff. in 
total cholesterol 
or HDL. 
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Soenen 201014 24 20-42 
years 
µ 31 
years 
Adults (good 
health, stable 
body weight) 
3 mo. HP: 
Isoenergetic 
Incr. via 
protein 
supp. (52g) 
(200g 
fruit/300g 
veg) 
Control: 
Isoenergetic 
Carb/Fat 
Supp. 
(200g 
fruit/300g 
veg) 
ad libitum 
dieting 
 
consultation to 
ensure proper 
supp. Intake 
Body Fat % 
decreased in HP 
group vs. control. 
 
Fat-free mass 
incr. in HP group, 
fat mass dec. in 
HP. (Control 
unchanged). 
 
Physical Activity 
Unchanged 
 
Weight Stable 
Soenen 201215 139 
(132) 
23-71 
years 
µ 50±12 
years 
Overweight/O
bese 
BMI 27-60 
µ 37±6 
12 
months: 
total 
3 months: 
33% 
energy 
req. 
9 months: 
67: energy 
req. 
HP 
P/C/F 
3 mo. (33%) 
HPLC: 
60/5/35% 
HPNC: 
60/35/5% 
9 mo. (67%) 
HPLC: 
30/25/45% 
HPNC: 
30/45/25% 
NP 
P/C/F 
3 mo. (33%) 
NPLC: 
30/5/65% 
NPNC: 
30/35/35% 
9 mo. (67%) 
NPLC:15/25
/60% 
NPNC: 
15/45/40% 
Macro 
composition 
adjusted for 
absolute 
protein intake 
 
24 hour urinary 
analysis to 
ensure protein 
intake 
 
Group-
organized 
program 
 
Prescribed, 
unique menus 
for each group 
HP had sig. effect 
on weight loss vs. 
NP at 3+12 
months. (similar 
relationship not 
seen with LC and 
NC groups) 
 
Relationships 
between changes 
in BW, FM, FFM 
and % energy 
intake dietary fat 
not significant. 
 
HPNC vs. all 
other diets 
reduced diastolic 
BP more. 
 
All groups, sig. 
decr. In BW and 
FM at 3 months, 
12 months. 
 
Weight loss + 
12 
 
weight-main. 
depend on protein 
component of 
dietary 
interventions but 
not on carb. 
component. 
Tang et al 201328 (55) 43 ≥ 21 
years 
µ 43 
years 
Men 
(Obese/Over
weight 
groups) 
BMI µ 31.5 
(25-39.9) 
1+12 wk HP: 
25/50/25 
(F/C/P) 
NP: 
25/60/15 
(F/C/P) 
Dietary 
Counseling 
Daily Food 
Checklist 
(turned in 
weekly) 
Both groups 
comparable body 
weight, fat loss. 
 
HP group lost 
less lean body 
mass than NP 
group. 
 
No sig. diff. in 
other factors 
(HDL-C, 
cholesterol, 
glucose, etc..) 
 
Obese: greater 
reductions in TAG 
Overweight: 
better 
preservation of 
LBM 
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Te Morenga et al 
2011 
87 (72) 18-65 
years 
µ 40-43 
years 
Overweight/O
bese Women 
BMI ≥ 27 
BMI µ 33-34 
8 weeks 
 
(2000-
4000 
kJ/day 
energy 
deficit, 
total 
energy 
never 
below 
5500 
kJ/day) 
HP 
P:28(5)% 
C:40(6)% 
F: 29(5)% 
Av. Values 
(SD) 
Hfib (>35g) -
HC 
P: 22(3)% 
C: 51(6)% 
F: 23(6)% 
Av. Values 
(SD) 
3DFR 
 
Dietary 
reccomendatio
ns, some 
provided food 
items (changed 
for diet group) 
Both diets were 
effective at 
reducing body 
weight, total body 
fat, and waist 
circumference. 
 
HP lost more 
body weight+total 
body fat and 
reduced diastolic 
BP to a greater 
degree. 
 
Both diets were 
effective at 
reducing 
total+LDL 
cholesterol, 
TAG's, fasting 
glucose, and BP.  
No sig. diff. 
between diet 
groups. 
Meta-
analyses/Reviews                 
Santesso et al 2012 74 
studies 
> 18 
years 
µ 45 
years 
Adults 
At least 80%, 
no medically 
indicated 
dietary 
restrictions 
 
BMI µ 33 
(22-43) 
≥ 28 days High Protein Low Protein 
 
(5% 
difference 
between HP 
and LP, in 
terms of % 
of total 
energy 
intake from 
protein) 
N/A Pooled 
standardized 
effect sizes 
(small-moderate) 
favored HP diets 
for: Weight Loss, 
BMI, Waist circ., 
BP (D+S), HDL, 
insulin, and 
TAGs. 
 
No sig. effects: 
total chol., LDL, 
C-reactive 
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proteins, HbA1c, 
glucose, and 
surrogates for 
bone/kidney 
health. 
 
Multivariable 
meta-regresion 
showed no 
signficant dose 
response with 
higher protein 
intake. 
Wycherley et al 2012 24 
studies 
 
1063 
indiv. 
≥18 years Adults ≥4 weeks 
µ 12.1 ± 
9.3 weeks 
HP 
(Macro %) 
P:µ 
30.5±2.4% 
C:µ 
41.6±3.5% 
F:µ 
27.8±3.2% 
SP 
(Macro %) 
P:µ 
17.5±1.5% 
C:µ 
56.0±3.3% 
F:µ 
25.1±3.1% 
N/A HP: greater 
reduction in 
weight, FM, and 
TAGs, lower 
reduction of FFM 
 
No sig. diff. in 
total chol, LDL, 
HDL, BP, insulin, 
or glucose. 
Crossover Trials 
Appel et al 200531 164 >30 years 
µ 54 
years 
Healthy 
adults, 
Hypertensive 
BMI: 30 
3-period, 6 
weeks/fee
ding 
period 
Protein-rich 
P: 25% 
C: 48% 
F: 27% 
C-rich 
P/C/F 
15/58/33% 
 
Unsat. Fat 
Rich 
P/C/F 
15/48/37% 
7-day menu 
cycle 
 
All food 
provided and 
prepared on-
site. 
BP, LDL chol. 
Decr. From 
baseline in all 
groups. 
 
When compared 
with CHO diet, 
HP diet showed 
greater decr. 
Systolic BP, LDL-
C, and TAG's. 
 
When compared 
to CHO, Unsat. 
Fat diet showed 
larger decreased 
15 
 
in systolic BP, 
decr. TAG's, incr. 
HDL (No diff. 
between LDL 
changes) 
Jenkins et al 200132 20 35-71 
years 
µ 
55.6±1.9 
years 
Hyperlipidemi
c 
Men/Women 
 
BMI 20.3-31.2 
BMI µ 26±0.7 
1 
month/diet 
HP 
(% total 
energy 
intake) 
P: 
27.4±0.3% 
C: 
46.7±0.4% 
F: 
25.6±0.4% 
Control 
(% total 
energy 
intake) 
P: 
15.6±0.3% 
C: 
58.6±0.5% 
F: 
25.5±0.5% 
Macronutrient-
controlled 
dietary 
supplement 
(bread, control 
and HP) 
No sig. diff. in 
total cholesterol, 
HDL-C. 
 
HP diet: greater 
decr. In TAG, uric 
acid, and 
creatinine, high 
conc. Of urea, 
and higher 24H 
urinary urea 
output. 
 
Lower amount of 
LDL oxidation in 
HP group. 
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High-Protein Study Outcome(s) 
Randomized Controlled Trials 
Crossover 
Trials Total Study Outcome # Studies Recorded 
Meta-
analyses/Re
v. 
Outcomes 
B
e
l
o
b
r
a
j
d
i
c
 
e
t
 
a
l
 
2
0
1
0
2
9
B
r
i
n
k
w
o
r
t
h
 
e
t
 
a
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2
0
0
4
1
2
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l
a
e
s
s
e
n
s
 
e
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a
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2
0
0
9
1
3
 
D
u
e
 
e
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a
l
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2
0
0
4
1
6
 
F
a
r
n
s
w
o
r
t
h
 
e
t
 
a
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2
0
0
3
1
7
 
F
l
e
c
h
t
n
e
r
-
M
o
r
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e
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a
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2
0
1
0
1
8
 
K
r
e
b
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e
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a
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2
0
1
0
1
9
 
L
a
s
k
e
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e
t
 
a
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2
0
0
8
2
0
 
L
a
y
m
a
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e
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a
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2
0
0
9
2
1
 
L
e
i
d
y
 
e
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a
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2
0
0
7
2
2
 
L
u
s
c
o
m
b
e
-
M
a
r
s
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e
t
 
a
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2
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0
5
2
4
 
M
u
z
i
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e
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a
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2
0
0
7
2
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N
o
a
k
e
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a
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2
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0
5
2
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S
a
c
k
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e
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a
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2
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0
9
2
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S
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o
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e
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a
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1
9
9
9
2
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o
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n
e
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0
1
0
1
4
 
S
o
e
n
e
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0
1
2
1
5
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a
n
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e
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a
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0
1
3
2
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T
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M
o
r
e
n
g
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a
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2
0
1
1
3
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A
p
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2
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0
5
3
1
 
J
e
n
k
i
n
s
 
e
t
 
a
l
 
2
0
0
1
3
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S
a
n
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e
s
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2
0
1
2
 
W
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2
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1
2
 
Weight-Loss = = P P = P P = = = = = = = P = P = P 0 0 7P 19 P P 
Total Cholesterol 0 
N
S = = = = = = 
HC
(4) = = = = = = 0 = = = NS = 1C 19 = = 
LDL-C 0 
N
S = = = = = 
H
C 
HC
(4) = = 
H
C = 
H
C = 0 = = = P = 
4HC, 
1P 19 = = 
HDL-C 0 = = = = P = P P = = 
N
S = 
L
C = 0 = =   
USF
R = 
3P, 
2O 19 P = 
TAG's 0 
N
S P P P P P P P P = P P = P 0 = = = 
P/U
SFR P 13P 19 P P 
Adiposity = = P P = P P P P = = = = = P P P = P 0 0 10P 19 = P 
Abdominal Adiposity P 0 P P = P 0 0 0 0 = = = = P P = 0 = 0 0 6P 13 P 0 
                                                    
P= protein more sig. 
result                                                   
0= Data Not Recorded                                                   
(=)No sig. diff. between 
groups                                                   
Others = other group 
more sig. result                                                   
NS=No significant 
change for any group                                                   
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